Immunex Enbrel Building Sales Force For Psoriatic Arthritis Approval

Immunex is building its first internal Enbrel sales force in preparation for etanercept's sBLA approval for psoriatic arthritis, Commercial Operations General Manager Mark Booth announced Aug. 20 during the company's R&D update in Seattle.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet